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ABSTRACT
The heterogeneous nuclear ribonucleoprotein
Npl3p of budding yeast is a substrate of
arginine methyltransferase Hmt1p, but the role of
Hmt1p in regulating Npl3p’s functions in tran-
scription antitermination and elongation were
unknown. We found that mutants lacking Hmt1p
methyltransferase activity exhibit reduced
recruitment of Npl3p, but elevated recruitment of
a component of mRNA cleavage/termination factor
CFI, to the activated GAL10-GAL7 locus. Consistent
with this, hmt1 mutants displayed increased
termination at the defective gal10-D56 terminator.
Remarkably, hmt1D cells also exhibit dimin-
ished recruitment of elongation factor Tho2p and
a reduced rate of transcription elongation in vivo.
Importantly, the defects in Npl3p and Tho2p
recruitment, antitermination and elongation in
hmt1D cells all were mitigated by substitutions in
Npl3p RGG repeats that functionally mimic
arginine methylation by Hmt1p. Thus, Hmt1p
promotes elongation and suppresses termination
at cryptic terminators by methylating RGG repeats
in Npl3p. As Hmt1p stimulates dissociation of Tho2p
from an Npl3p-mRNP complex, it could act to
recycle these elongation and antitermination
factors back to sites of ongoing transcription.
INTRODUCTION
Termination of transcription by RNA polymerase II
(RNAP II) is an important step of gene regulation
in eukaryotes (1). Whereas premature transcription
termination produces truncated and defective transcripts,
expression of downstream genes is impaired if transcrip-
tion reads through from upstream terminators (2–4).
Transcription termination is coupled to 30-end processing
of mRNA in which cleavage and polyadenylation are
performed by a multiprotein complex that contains
cleavage and polyadenylation speciﬁcity factors (CPSF)
and cleavage factor I (CFI) (2,3). Two models known as
the ‘torpedo’ and ‘anti-terminator’ models have been
proposed to explain the mechanism of transcription ter-
mination. According to the ‘torpedo’ model, cleavage of
RNA at the poly(A) site triggers rapid degradation of the
30 RNA by exonuclease Rat1p and subsequent release of
RNAP II (4–6). In the ‘anti-terminator’ model, transcrip-
tion through the poly(A) site evokes a conformational
change in the elongation complex, involving recruitment
of CPSF and CFI and attendant release of positive elon-
gation factors and antitermination factors. The resulting
decrease in the processivity of RNAP II provokes tran-
scription termination (2). Termination on many genes was
found to occur at various positions depending on the
growth conditions (7), and cryptic termination sites rich
in AU nucleotides are frequently found within open
reading frames (ORFs) (8,9). Therefore, the selection of
transcription termination sites is not determined solely by
cis-acting sequence elements at the termination site and,
plausibly, might also be regulated by post-translational
modiﬁcations of termination and antitermination
factors. However, the exact mechanism of selecting tran-
scription termination sites is not fully understood.
Npl3p is a heterogeneous nuclear ribonucleoprotein
with serine/arginine (SR) repeats. Its multiple functions
include the role of an antiterminator to impede tran-
scription termination at cryptic termination sites (8).
According to the current model, Npl3p prevents tran-
scription termination by competing with RNA cleavage
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factors, e.g. Hrp1p and Rna15p, for binding to nascent
transcripts (8,9). Npl3p exhibits a higher aﬃnity for RNA
than do Hrp1p and Rna15p (9), and hence functions as a
physical barrier impeding the binding of Hrp1p and
Rna15p to nascent transcripts. On the other hand,
Hrp1p and Rna15p, but not Npl3p, prefer AU-rich
sequences, a characteristic of strong termination sites
(9,10). Npl3p will thus be displaced by Hrp1p and
Rna15p at strong termination sites, leading to the
recruitment of other termination factors and cleavage of
the nascent transcript. Since the competition between
Npl3p and Hrp1p determines the choice of transcription
termination sites (7), it would be of great interest to under-
stand how transcription termination is regulated via
post-translational modiﬁcations of Npl3p.
Transcription termination has to be well-coordinated
with other steps of transcription, particularly elongation
(1). As such, the elongation rate can inﬂuence termination
through the action of positive elongation factors such as
Spt4p, Spt6p and Paf1p, which are known to inhibit
termination (1,8). Consistent with the concept that elon-
gation and termination are co-regulated; Npl3p can
interact with RNAP II and stimulate transcription elon-
gation directly in vitro (11). However, it is not understood
whether Npl3p promotes transcription elongation in vivo.
In addition, the mechanisms by which Npl3p modulates
transcription elongation and coordinates it with
termination remain to be elucidated.
RNA-binding aﬃnity and cellular localization of Npl3p
can be modulated by post-translational modiﬁcations,
including methylation (in the nucleus) (12,13) and
phosphorylation (mainly in the cytoplasm) (14,15).
Although RNA binding by Npl3p in vivo is appar-
ently unaﬀected by arginine methylation (12),
hypophosphorylation and methylation of Npl3p are
suggested to be important for its export together
with mRNA from the nucleus (12,15–17). Interestingly,
phosphorylation of Npl3p by casein kinase II (CK2) was
also suggested to contribute to Npl3p dissociation
from the nascent transcript and hence to promote the
recruitment of termination factor Rna15p in vitro (11).
Npl3p is most heavily methylated in the nucleus (13,15),
and there is evidence that its methylation is important
in nuclear export of the Npl3-mRNA complex (12,13)
and also in splicing (18). However, the role of Npl3p
methylation in its transcription antitermination function
is unclear.
Hmt1p is an arginine methyltransferase that catalyzes
the methylation of arginine residues in several
mRNA-binding proteins including Npl3p to facilitate
their export from the nucleus (12,13). Methylation by
Hmt1p also weakens Npl3p association with Tho2p, a
subunit of the THO and TREX complexes, which stimu-
late elongation and mRNA nuclear export, respectively
(13). Replacement of all 15 arginines in Npl3p’s Arg–
Gly–Gly (RGG) repeats with lysines (the Npl3RKp
variant) reduces Npl3p’s interaction with Tho2p and
restores its nuclear export in hmt1D cells. This ﬁnding sug-
gested that methylation masks the RGG repeats, and that
lysine substitutions partially mimic methylation to permit
Npl3p dissociation from Tho2p and its nuclear export in
the absence of Hmt1p (12,13). Because Npl3RKp also
restores nuclear export of Hrp1p in hmt1D cells, it
appears that methylation of Npl3p, but not of Hrp1p
itself, is crucial for Hrp1p export (12).
In this study, we hypothesized that Hmt1p might aﬀect
the selection of transcription termination sites by
inﬂuencing the recruitment of Npl3p or Hrp1p to sites
of transcription. We provide evidence that methylation
of the RGG repeats in Npl3p by Hmt1p promotes
antitermination at a weak terminator, and that it also
stimulates elongation at least partly by stimulating
Tho2p recruitment to sites of transcription. Our results
suggest that the ability of Hmt1p to regulate the interac-
tion between Npl3p and Tho2p on nascent mRNAs
might provide an important feedback mechanism to
couple the rate of transcription elongation with that of
mRNA nuclear export.
MATERIALS AND METHODS
Yeast strains and growth conditions
All yeast strains and plasmids used in this work are listed
in Tables 1 and 2, respectively. The BY4741 deletion
derivatives were described earlier (19) and purchased
Table 1. List of yeast strains
Name Parent Relevant Genotype Reference
BY4741 mata his3-D1 leu2-D0 met15-D0 ura3-D0
3171 BY4741 hmt1D::KanMX4 Open Biosystems
CMY201 BY4741 hmt1D::KanMX4 NPL3-myc13 This work
CMY202 BY4741 hmt1D::KanMX4 THO2-myc13 This work
CMY203 BY4741 hmt1D::KanMX4 HRP1-myc13 This work
CMY127 BY4741 gal10-D56 (23)
CMY223 BY4741 hmt1D::KanMX4 gal10-D56 This work
CMY129 BY4741 npl3D::KanMX4 gal10-D56 (23)
CMY125 BY4741 PGAL1-YLR454w This work
CMY130 BY4741 hmt1D::KanMX4 PGAL1-YLR454w (23)
W303 mata leu2 ura3 lys2 trp1 his3
YAM533 W303 hmt1D::HIS3 NPL3-myc::URA3 (13)
YAM534 W303 hmt1D::HIS3 npl3RK- myc::URA3 (13)
YAM535 W303 NPL3-myc::URA3 (13)
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from Open Biosystems. The presence of all reported
deletion alleles was conﬁrmed by PCR ampliﬁcation and
complementation of mutant phenotypes by plasmid-borne
WT genes. Myc-tagged strains were constructed as
described (20). gal10-D56 mutants were constructed as
detailed elsewhere (21). The PGAL1-YLR454w strains
were constructed as described earlier (22). All strains
were veriﬁed by PCR analysis.
Biochemical methods
The ChIP experiments were conducted as described earlier
(23) using the primers listed in Table 3. Northern blot
analysis of total RNA was carried out as described
earlier (23). Western blot analysis of whole-cell extracts
was conducted using extracts prepared by trichloroacetic
acid precipitation (24). Antibodies employed were
monoclonal anti-Myc (Roche), anti-Rpb3p (Neoclone)
and anti-Pgk1p (Invitrogen). GLAM assay was conducted
as described earlier (25).
RESULTS
Deletion of HMT1 increases termination at the
defective terminator of gal10-D56 in vivo
Deletion of HMT1 is synthetically lethal with deletion of
NPL3 (13,26–28) or CBP80 (26). Npl3p can stimulate
elongation in vitro (11) and it inhibits termination in vivo
(8,9). Cbp80p has also been shown to promote
antitermination in vivo (23,29). Therefore, we hypoth-
esized that Hmt1p might play a role in transcription elon-
gation or antitermination. To test this hypothesis, the
eﬀect of hmt1D on transcription of the gal10-D56 allele
was examined. The D56 mutation eliminates 55 bp at the
30 end of GAL10 and reduces the eﬃciency of 30-end for-
mation at the correct site, allowing read-through (RT) into
the GAL7 gene downstream. Gal7p is not expressed from
the RT bicistronic transcript, and the production of native
GAL7 mRNA is impaired by transcription elongation
across the GAL7 promoter—both features contributing
to the Gal– phenotype of gal10-D56 cells (Figure 1A) (21).
Table 3. List of primers
Gene (region) Location (relative to ATG) Sequence References
PGAL1-YLR454w
TATA 194/+35 50-CTGGGGTAATTAATCAGCGAAGCGATG-30 (22)
50-CACTTGTACAGTAGAACATTAATCGGAAAC-30
2 kb +1986/+2199 50-CATATCATCCACCCTAGGTGCTAGGTCGG-30 (22)
50-GAGCTGACCAGACCTAACCATAGTAGCGTG-30
4 kb +4069/+4268 50-AGATATTACTCGTTGTTCGTGCCCAG-30 (22)
50-CCCAAAACCCTAGTTAACAGAAGGATC-30*
6 kb +5904/+6074 50-CGTACTGTTGAAATGGAACGAGGACGC-30 (22)
50-ATCGCTTCCATACTCGTTGTATCATCAGTC-30
8 kb +7701/+7850 50-GAGGGTCACAGATCTATTACTTGCCC-30 (22)
50-GTTGTGAGTTGCTTCAGTGGTGAAGTG-30
Chr I N.A. 50-GTTTATAGCGGGCATTATGCGTAGATCAG-30 (22)
50-GTTCCTCTAGAATTTTTCCACTCGCACATTC-30
GAL10-GAL7
A 58/+182 50-TTAAACTTCTTTGCGTCCATCC-30 (8)
50-TGCTTGGTCAAGACCTCTAACC-30
B +823/+1108 50-TGTCGTGAGTGGAACTTGGGTT-30 (8)
50-GCATATCTTCAGCGGAAAATCTGGC-30
C +1869/+2102 50-TGTCAAGGTTTTCATCCCGATTC-30 This work
50-AAGAAGGATAGTAAGCTGGCAA-30
D +2323/+2604 50-ATGGACGGTAGCAACAAGAATA-30 (8)
50-TGGGTTAAGGAAAATGACAGAA-30
E 203/+38 50-CAAAAAGCGCTCGGACAACT-30 (8)
50-TGGGAATGGCTAGAAAAATCAA-30
Chr V N.A. 50-GGCTGTCAGAATATGGGGCCGTAGTA-30 (8)
5’-CACCCCGAAGCTGCTTTCACAATAC-30
*The sequence of this oligonucleotide was re-designed in this study.
Table 2. List of plasmids
Original name Relevant components References
npl3RK pAM409 CEN LEU2 pNop-PrA-npl3-RK1-15* (15)
NPL3 pPS2389 CEN LEU2 pNop-PrA-NPL3* (13)
hmt1-G68R pPS1752 CEN LEU2 hmt1-G68R (32)
hmt-G68A pPS1753 CEN LEU2 hmt1-G68A (32)
HMT1 pPS1305 CEN LEU2 HMT1 (32)
pSCh202 pSCh202 2m URA3 PGAL-PHO5 (25)
pSCh209-LAC4 pSCh209-LAC4 2m URA3 PGAL-PHO5::LAC4 (25)
*The plasmids express protein A (PrA) fusion protein driven by NOP1 promoter.
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In agreement with previous ﬁndings, gal10-D56 cells
could not grow on galactose medium (Figure 1B, Row 3
versus 1) (23). Interestingly, hmt1D gal10-D56 cells were
able to grow on galactose medium (Figure 1B, Row 4
versus 3). The Gal+ phenotype of hmt1D gal10-D56 cells
could be complemented with plasmid-borne wild-type
HMT1 (Figure 1B, Row 7 versus 4), but not by
hmt1-G68A or hmt1-G68R (Figure 1B, Rows 5 and 6
versus 7), whose products exhibit weakened or no
arginine methyltransferase activity, respectively (13).
Northern blot analysis conﬁrmed that the Gal+
phenotype of hmt1D gal10-D56 cells could be attributed
to an increased level of GAL7 mRNA level and a reduced
amount of GAL10-GAL7 RT transcript; as such, the ratio
of GAL7 to GAL10-GAL7 RT transcripts (GAL7/RT) was
increased more than 2-fold in hmt1D gal10-D56 cells
(Figure 1C, lane 4 versus 2). This suggests that elimination
of Hmt1p increases termination at the defective gal10-D56
terminator.
Hmt1p is required for eﬃcient transcription elongation
The increased termination at gal10-D56 in hmt1D cells
could result from a decreased transcription elongation
rate or increased termination eﬃciency (9). In order to
dissect the role of Hmt1p in this context, the rate and
processivity of transcription elongation were examined
in hmt1D cells by using the ChIP assay to measure
occupancies of RNAP II subunit Rpb3p across the
PGAL1-YLR454w gene, in which the 8-kb YLR454w
ORF is placed under the control of the GAL1 promoter
(Figure 2A) (25). On glucose addition to cells growing in
galactose, RNAP II recruitment to the promoter ceases
and elongating RNAP II molecules ﬁnish transcribing
the ORF. The kinetics of Rpb3p disappearance from the
ORF during this last wave of elongation represents the
elongation rate in vivo (22). Interestingly, it appeared
that hmt1D cells exhibited a moderate decrease in the elon-
gation rate versus wild-type HMT1 cells, which was
evident at 4min after glucose treatment (Figure 2, panel
C versus B). The slower run-oﬀ of RNAP II from the
YLR454w ORF in hmt1D cells was observed consistently
in replicate experiments. To investigate whether the
methyltransferase activity of Hmt1p is required for its
function in transcription elongation, the ChIP analysis
was repeated after introducing plasmid-borne HMT1 or
mutant hmt1-G68R into hmt1D cells. Transformants
harboring wild-type HMT1 exhibited a signiﬁcantly
higher elongation rate than those containing hmt1-G68R
(Figure 2, Panel F versus E) or empty vector (Figure 2,
panel G versus E). Thus, the arginine methyltransferase
activity of Hmt1p is required for a wild-type rate of tran-
scription elongation in vivo. The lower rate of elongation
in hmt1D cells might contribute to the increased frequency
of termination we observed at the defective terminator of
gal10-D56.
Processivity of RNAP II during elongation can be
examined by comparing the Rpb3p occupancy at the
50 and 30 ends of YLR454w in cells grown in galactose
(22). Because no appreciable diﬀerence was found in
Rpb3p occupancy at PGAL1-YLR454w between wild-type
and hmt1D cells grown in galactose (Figure 2D), we
conclude that elimination of Hmt1p does not produce a
detectable decrease in the processivity of elongating
RNAP II.
Recruitment of Npl3p and Hrp1p is regulated by the
arginine methyltransferase activity of Hmt1p
Apart from stimulating transcription elongation, Hmt1p
might reduce recognition of defective terminators by
promoting recruitment of Npl3p, or impeding that of
Figure 1. Hmt1p reduces termination at the defective gal10-D56 terminator. (A) Diagram summarizing results in (B) and (C) indicating that hmt1D
increases termination at the gal10-D56 terminator, reducing the RT transcript while increasing GAL7 transcript abundance, thereby suppressing the
Gal phenotype in gal10-D56 cells. (B) Serially diluted strains of the indicated genotypes were spotted on synthetic complete medium lacking leucine
(SC-LEU) plates containing 2% glucose (left) or 2% galactose (right) and incubated for 4 days. (C) Upper panel: northern blot analysis of GAL7 and
RT transcripts. Total RNA (20 mg) from indicated strains induced with 2% galactose for 3 h were resolved and probed for GAL7 mRNA. The GAL7/
RT ratios were determined by densitometry. The values indicated are the means and standard deviations of ratios calculated from three replicate
experiments, which gave highly similar results. Lower panel: ethidium bromide staining of the gel.
2220 Nucleic Acids Research, 2010, Vol. 38, No. 7
Hrp1p, to the transcribed ORF. Hmt1p methylates Npl3p
(13) and Hrp1p (12), and deletion of HMT1 provokes
accumulation of both proteins in the nucleus (30),
although the accumulation of Hrp1p is dependent on
Npl3p (15). In addition, a genome-wide binding study
revealed a slight change in Npl3p genomic occupancy
and a more dramatic alteration in Hrp1p recruitment in
hmt1D cells (31). To determine whether Npl3p and Hrp1p
recruitment to a native termination site might be regulated
by Hmt1p, ChIP assays were performed to examine the
Figure 2. hmt1D reduces the rate of transcription elongation in vivo. (A) Diagram of the PGAL1-YLR454w gene with positions of PCR primers
indicated (in bp) from nucleotide A of the start codon. (B, C) Quantiﬁcation of Rpb3p occupancy measured by ChIP with antiRpb3p antibodies at
the ﬁve positions across PGAL1-YLR454w indicated in (A) for HMT1 (CMY125) (B) or hmt1D (CMY130) (C). Cells grown in YP containing
galactose were treated with 4% glucose for the indicated times. DNA extracted from immunoprecipitates and input chromatin samples was ampliﬁed
by PCR in the presence of [33P]dATP for the diﬀerent regions of PGAL1-YLR454w, together with a fragment from a non-transcribed region of Chr I
to control for non-speciﬁc immunoprecipitation. PCR products were quantiﬁed with by phosphorimaging and ratios of experimental-to-control
signals in the immunoprecipitates were normalized for the corresponding ratios for input samples to yield the occupancy values. Occupancies were
normalized to those derived from cells grown in 2% galactose for 2 h (time=0). (D) hmt1D does not detectably aﬀect RNAP II processivity in vivo.
HMT1 and hmt1D cells were grown in galactose medium (time=0) and quantiﬁcation of Rpb3p occupancy was performed as above. The value at
each position was normalized to that of the WT strain. (EG) Methyltransferase activity of Hmt1p stimulates the rate of transcription elongation in
vivo. hmt1D cells containing empty vector (E) or plasmids harboring hmt1-G68R (F) or HMT1 (G) were induced with SC-LEU 2% galactose for 2 h
(time=0) and treated with 4% glucose for the indicated times. ChIP analysis of Rpb3p across the PGAL1-YLR454w gene was conducted as described
earlier. Average results obtained from two independent cultures and two PCR ampliﬁcations for each culture were plotted in the histograms.
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eﬀect of eliminating Hmt1p on occupancy of Npl3p and
Hrp1p at GAL10-GAL7. Consistent with previous ﬁndings
(8), in hmt1D cells harboring wild-type HMT1, Npl3p was
found in all regions of GAL10 (Figure 3B, Lanes 16–20;
also see Figure 3C, Lanes 16–20 for quantiﬁcation).
Remarkably, the hmt1D cells containing empty vector
showed greatly reduced Npl3p recruitment (Figure 3B
and C, Lanes 1–5 versus 16–20) particularly in the
promoter (region A) and middle region (region B) of the
GAL10 ORF (Figure 3B and C, Lanes 1 and 2 versus 16
and 17). Moreover, Npl3p recruitment could not be
restored by either hmt1-G68A or hmt1-G68R (Figure 3B
and C, Lanes 6 and 7, and 11 and 12). In agreement with
previous ﬁndings (13, 31), Western blot analysis revealed
no diﬀerences in myc-Npl3p levels among these diﬀerent
strains (Figure 3D). These results suggested that the
arginine methyltransferase activity of Hmt1p is required
for strong Npl3p recruitment to the GAL10-GAL7 locus.
As Npl3p is thought to function as an antitermination
factor by competing with cleavage factors such as Hrp1p
for binding to cryptic termination sites (8), we also
examined the eﬀect of eliminating Hmt1p on Hrp1p occu-
pancy at GAL10-GAL7. Interestingly, deletion of HMT1
led to increased Hrp1p recruitment at GAL10, particularly
to the middle region B (Figure 3B and 3E, Lane 2 versus
17). Again, the change in Hrp1p occupancy was depen-
dent on the arginine methyltransferase activity of Hmt1p,
as the Hrp1p occupancy in the middle to 30 region of
GAL10 in hmt1-G68A and hmt1-G68R cells was higher
than in HMT1 cells (Figure 3B and E, Lanes7–8 and
12–13 versus 17–18). As expected from previous ﬁndings
(31), we observed no diﬀerences in Hrp1p levels associated
with the diﬀerent HMT1 alleles (Figure 3F). Thus,
although both Npl3p and Hrp1p are concentrated in the
nucleus of hmt1D cells (32), Npl3p recruitment to the
highly transcribed GAL10-GAL7 locus was reduced,
whereas Hrp1p recruitment was increased in hmt1D cells.
Plausibly, Hmt1p could suppress Hrp1p recruitment
indirectly by stimulating Npl3p occupancy at GAL10.
The dramatically decreased ratio of Npl3p to Hrp1p occu-
pancy found in hmt1D cells (Figure 3C and E) might con-
tribute to the increased recognition of the defective gal10-
D56 terminator we observed in hmt1D gal10-D56 cells
(Figure 1B and C).
Hmt1p regulates Npl3p recruitment, anti-termination and
transcription elongation by methylating RGG repeats in
Npl3p
Replacing all 15 RGG repeats in Npl3p with KGG repeats
partially mimics the eﬀect of methylation by Hmt1p and
facilitates Npl3p dissociation from Tho2p and nuclear
export in hmt1D cells (12,13). We wished to determine
whether the KGG substitutions in Npl3RKp would also
reduce the requirement for Hmt1p in eﬃcient Npl3p
recruitment, as this would imply that Hmt1p stimulates
Npl3p recruitment directly by methylating RGG repeats.
In agreement with results in Figure 3, deletion of HMT1
impaired Npl3p recruitment to GAL10-GAL7 (Figure 4A,
Lanes 6–10 versus 1–5). Interestingly, however, recruit-
ment of Npl3RKp was considerably less dependent on
Hmt1p than is wild-type Npl3p (Figure 4A, Lanes 11–15
versus 6–10). Comparing Npl3RKp recruitment in hmt1D
cells to that of wild-type Npl3p in HMT1 cells reveals
lower occupancies for Npl3RKp at the 50 and middle
regions of GAL10 (regions A and B, respectively)
(Figure 4A, Lanes 11–12 versus 1–2), but similar
occupancies in the 30 region of GAL10 and promoter
region of GAL7 (regions D and E, respectively)
(Figure 4A, Lanes 14–15 versus 4–5). In agreement with
previous ﬁndings (13, 31), western analysis indicated that
there are no diﬀerences in expression levels of myc-Npl3p
or myc-npl3RKp among the three strains (Figure 4H).
These ﬁndings suggested that Npl3RKp might function
as an antitermination factor in hmt1D cells as eﬀectively
as wild-type Npl3p does in HMT1 cells.
To address this possibility, we ﬁrst asked whether the
KGG substitutions would impair the antitermination
function of Npl3p. As described in our previous study
(23), npl3D suppressed the Gal phenotype conferred by
gal10-D56, allowing modest growth on YP+Gal medium
(Figure 4B, right panel, Row 4 versus 3) despite the fact
that npl3D confers a strong slow growth phenotype on this
medium even in the presence of wild-type GAL10
(Figure 4B, right panel, Row 2 versus 1). Importantly,
the npl3RK mutant was indistinguishable from wild-type
NPL3 in reversing the ability of npl3D gal10-D56 cells to
grow on YP+Gal (Figure 4B, right panel, Rows 7–8
versus 4), as well as in complementing the slow growth
phenotype of npl3DGAL10 cells in this medium
(Figure 4B, right panel Rows 5 and 6 versus 2). In line
with the Gal phenotypes, northern blot analysis showed
that both npl3RK and NPL3 conferred a strong reduction
in GAL7 mRNA and elevated levels of GAL10-GAL7 RT
transcripts in npl3D gal10-D56 cells (Figure 4C, Lanes 4–5
versus 3). In fact, npl3RK provoked a lower GAL7/RT
ratio than did wild-type NPL3 (Figure 4C, Lane 4
versus 5), indicating that Npl3RKp actually has a higher
level of antitermination activity than wild-type Npl3p.
Having found that Npl3RKp has antitermination
function and is recruited independently of Hmt1p, we
tested whether Npl3RKp could suppress the reduced
antitermination phenotype in hmt1D cells. In agreement
with our ﬁndings in Figure 1B, hmt1D partially suppressed
the Gal phenotype of gal10D-56 cells, which we
attributed to increased recognition of the defective
GAL10 terminator and greater production of GAL7
mRNA (Figure 1C). Interestingly, over-expression of
Npl3RKp but not wild-type Npl3p, reversed this
eﬀect of hmt1D and restored the Gal phenotype in
hmt1Dgal10D-56 cells (Figure 4D, Rows 5 versus. 3, and
Rows 4 versus 3). This ﬁnding suggests that the
antitermination function of Npl3RKp is independent
of Hmt1p.
We also asked whether Npl3RKp could rescue the tran-
scription elongation defect in hmt1D cells. Using the same
ChIP assay employed in Figure 2 to measure the transcrip-
tion elongation rate at PGAL1-YLR454w, we found that
overexpressing Npl3RKp signiﬁcantly reduced the elonga-
tion defect in hmt1D cells (Figure 4E–G), while this was
not observed in cells over-expressing wild-type Npl3p
(data not shown).
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Methylation of Npl3p by Hmt1p facilitates
co-transcriptional recruitment of THO/TREX
There is evidence that Hmt1p methylation of Npl3p
reduces its interaction with transcription elongation
factor Tho2p (13,31), and that the KGG substitutions in
Npl3p partially bypass the requirement for Hmt1p in
reducing Npl3p-Tho2p association (13). We hypothesized
that the elongation defect in hmt1D cells involves seques-
tration of Npl3p and Tho2p in nuclear mRNPs that are
not competent for export with attendant impairment of
Tho2p recruitment by elongating RNAP II. Consistent
with this idea, ChIP analysis showed that cells lacking
Figure 3. Loss of HMT1 aﬀects Npl3p and Hrp1p occupancies at activated GAL10-GAL7. (A) Diagram of the GAL10-GAL7 locus, with PCR
primer pairs indicated with black bars and terminator labeled as ‘T’. (B) ChIP analysis of Npl3p (upper panel) and Hrp1p (middle panel) occupancies
across the GAL10-GAL7 locus. ChIP analysis of Myc-Npl3p or Myc-Hrp1p occupancies was conducted using antimyc antibodies as described in
Figure 2, except using primers to amplify diﬀerent regions of GAL10-GAL7 in panel A and to amplify non-transcribed region of Chr V was
conducted to control for non-speciﬁc immunoprecipitation. Upper panel, transformants of hmt1D NPL3-myc strain (CMY201) containing empty
vector (Lanes 1–5), or plasmids harboring hmt1-G68A (Lanes 6–10), hmt1-G68R (Lanes 11–15) or HMT1 (Lanes 16–20) were grown in SC-LEU
galactose medium. Middle panel, transformants of hmt1D HRP1-myc strain (CMY203) harboring the same plasmids described for the upper panel
were analyzed as described earlier. Lower panel: Analysis of input chromatin samples for the CMY201 transformants. (C) Quantiﬁcation of Npl3p
occupancy measured at the indicated positions. The ratios of experimental-to-control signals in the immunoprecipitate samples (B, upper panel) were
normalized for the corresponding ratios for input samples (B, lower panel) to yield the occupancy values. Average results obtained from two
independent cultures and two PCR ampliﬁcations for each culture were plotted. (D) Possible eﬀect of mutation or deletion of HMT1 on expression
of Myc-tagged Npl3p was analyzed by western blot analysis of WCEs of the relevant strains with antiMyc and antiPgk1p antibodies (to provide a
loading control). (E) Quantiﬁcation of Hrp1p occupancy measured at the indicated positions. The ratios of experimental to-control signals in the
immunoprecipitate samples (B, middle panel) were normalized for the corresponding ratios for input samples (B, lower panel) to yield the occupancy
values. Average results obtained from two independent cultures and two PCR ampliﬁcations for each culture were plotted. (F) Possible eﬀect of
mutation or deletion of HMT1 on expression of Myc-tagged Hrp1p was analyzed by western blot analysis of WCEs of the relevant strains with
antiMyc and antiPgk1p antibodies (to provide a loading control).
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Hmt1p or containing Hmt1p variants lacking arginine
methyltransferase activity displayed reduced Tho2p
occupancy in the middle region of the GAL10 ORF
compared with that seen in cells containing wild-type
Hmt1p (Figure 5A, Lanes 1–3 versus 4). Importantly,
over-expression of Npl3RKp, but not Npl3p, restored
Tho2p recruitment in hmt1D cells to the same level
observed in HMT1 cells with native levels of Npl3p
(Figure 5A, Lanes 5–6 versus 1 and 4). This eﬀect was
not due to diﬀerences in RNAP II occupancy at GAL10
in these strains (see comment) or Tho2p expression level
(data not shown) (13). These ﬁndings support the idea
that the transcription elongation defect in hmt1D cells
involves binding of non-methylated Npl3p to the THO
or TREX complex, thereby reducing the recruitment of
one or both of these elongation factor complexes to
elongating RNAP II.
Finally, we employed an assay for gene-length depen-
dent accumulation of mRNA (GLAM), which reveals
defects in transcription elongation, to provide further
support that Hmt1p stimulates elongation by methylating
Npl3p. The GLAM assay compares the expression of
reporters with the same promoter (PGAL) and PHO5
coding sequences for acid phosphatase, but harboring
Figure 4. Npl3RKp suppresses the antitermination and elongation rate defects caused by deletion of NPL3 or HMT1. (A) ChIP analysis of Npl3p or
Npl3RKp in HMT1 or hmt1D strains. HMT1 NPL3-myc (YAM535, Lanes 15), hmt1DNPL3-myc (YAM533, Lanes 610) and hmt1Dnpl3RK-myc
(YAM534, Lanes 1115) were analyzed and the Npl3p or Npl3RKp occupancies across the GAL10-GAL7 locus were determined as described in
Figure 3. Average results obtained from two independent cultures and two PCR ampliﬁcations for each culture were plotted. (B) Npl3RKp
suppresses the Gal+ phenotype (antitermination defect) of npl3Dgal10-D56 (CMY129) cells. npl3Dgal10-D56 cells transformed with empty vector,
NPL3 or npl3RK plasmid were spotted on YP plates containing either 2% glucose (Glu, left panel) or 2% galactose (Gal, right panels) as carbon
source and incubated for 3 days in YP. Note that YP was used instead of SC-LEU medium because the extreme slow-growth phenotype conferred by
npl3Don SC-LEU+Gal medium, evident in GAL10 cells, obscures suppression of the Gal phenotype of gal10-D56 by npl3D(data not shown).
(C) Northern blot analysis of GAL7 and GAL10-GAL7 RT mRNAs conducted as in Figure 1C. The values indicated are the means and standard
deviations of ratios calculated from three replicate experiments, which gave highly similar results. (D) Npl3RKp suppresses the Gal+ phenotype
(antitermination defect) of hmt1Dgal10-D56 (CMY223) cells. HMT1 gal10-D56 and hmt1Dgal10-D56 strains with plasmid-borne NPL3 or npl3RK
were spotted on SC-LEU plates containing 2% glucose (left) or 2% galactose (right) and incubated for 4 days. (E) ChIP analysis of Rpb3p
occupancy across the PGAL1-YLR454w locus after imposing glucose repression. hmt1D cells (CMY130) with or without plasmid-borne npl3RK
were induced with 2% galactose for 2 h (time=0) and treated with 4% glucose for the indicated times. ChIP assays were done as described in
Figure 2. PCR ampliﬁcations of input chromatin samples are labeled ‘In’; non-coding region on chromosome I (Chr I) was ampliﬁed as a control for
non-speciﬁc immunoprecipitation. (F, G) Quantiﬁcation of Rpb3p occupancies measured in (E) at the indicated positions at PGAL1-YLR454w in
hmt1D cells (F) and hmt1D cells containing npl3RK (G). Average results obtained from two independent cultures and two PCR ampliﬁcations for
each culture were plotted. (H) Possible eﬀect of hmt1D on Myc-tagged Npl3p and Myc-tagged Np3RKp levels was examined by western blot analysis
of WCEs from the relevant strains with antiMyc and antiPgk1p antibodies.
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Figure 5. Tho2p recruitment and gene length-dependent transcription defects in hmt1D cells are suppressed by npl3RK, and a hypothetical model for
the role of Hmt1p in recycling Tho2p and Npl3p from mRNPs to sites of transcription. ChIP analysis of Tho2p occupancy at the 50 region of GAL10
gene (region B in Fig. 3A) in hmt1D THO2-myc13 (CMY202) cells. Cells transformed with empty vector, or plasmids containing hmt1-G68A,
hmt1-G68R, HMT1, NPL3 or npl3RK were grown in SC-LEU with 2% galactose and ChIP analysis was conducted using antiMyc antibodies (to
measure Tho2p occupancy) or antibodies against Rpb3p (to measure RNAP II occupancy). Non-coding region on chromosome V (Chr V) was
ampliﬁed as control for non-speciﬁc immunoprecipitation. The occupancies were quantiﬁed and plotted for Tho2p (A) and Rpb3p (B). Average
results obtained from two independent cultures and two PCR ampliﬁcations for each culture were plotted. The occupancies of Tho2p at the GAL10
ORF are signiﬁcantly lower in control (hmt1D), G68A and G68R versus HMT1 cells, and in cells containing extra copies of NPL3 versus extra copies
of npl3RK, as judged by the Student’s t-test, with P< 0.01(*). (C) HMT1 (BY4741) and hmt1D (3171) cells transformed with reporter plasmid
pSCH209-LAC4 plus plasmids harboring hmt1-G68A, NPL3, npl3RK or empty vector were grown in SC-LEU-URA with 2% galactose. HMT1
(BY4741) and hmt1D (3171) cells harboring pSCH202 were analyzed as controls. Acid phosphatase activity was measured in cell lysates and the
GLAM ratio was calculated as the ratio of activities in transformants harboring pSCH209-LAC4 versus those containing pSCH202. Results are the
averages from three independent experiments and error bars indicate SD (D) Model depicting how Hmt1p regulates transcription elongation and
termination by methylating Npl3p. Upper panel: In WT cells, methylation of Npl3p by Hmt1p allow dissociation the TREX(Tho2p)Npl3pmRNP
to facilitate (1) TREX(Tho2p) recruitment to sites of transcription and (2) nuclear export of the Npl3pmRNP. Subsequent nuclear import and
methylation of Npl3p by Hmt1p enables its recruitment to sites of transcription (3). Npl3p and TREX both stimulate elongation and, by impeding
recruitment of Hrp1p (4), Npl3p prevents transcription termination at cryptic terminators. Middle panel, in hmt1D NPL3 cells, the failure to
methylate Npl3p causes Tho2p (TREX) and Npl3p to be sequestered in mRNPs that are not exported eﬃciently; the ensuing impaired recruitment
of TREX(Tho2p) and Npl3p to sites of transcription reduces the rate of elongation, and the resulting increased Hrp1p occupancy enables tran-
scription termination at cryptic terminators. Lower panel, in hmt1D npl3RK cells, TREX(Tho2p)-Npl3RKp-mRNP can dissociate independently of
Npl3p methylation to recycle TREX(Tho2p) and Npl3RKp back to sites of transcription where they stimulate elongation and block termination at
cryptic terminators, as occurs in WT cells.
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30 untranslated regions that diﬀer by 3 kb. Mutations
in elongation factors produce a greater reduction in
the steady-state amount of the long versus short tran-
script, and their encoded Pho5p enzyme activities
(decreased GLAM ratio) (25). In agreement with our
ﬁndings from the kinetic ChIP assay in Figures 2, and 4,
we found that hmt1D cells exhibit a signiﬁcantly lower
GLAM ratio than do HMT1 cells (Figure 5C, Lanes 1
versus 4), and the reduced GLAM ratio of hmt1Dcells
was complemented with plasmid-borne HMT1 but not
by hmt1G68R (Figure 5C, Lanes 5–6 versus 4).
Importantly, the reduced GLAM ratio of hmt1D cells
was suppressed by over-expressing npl3RK, but not by
over-expressing wild-type NPL3 (Figure 5C, Lanes 7–8
versus 4).
DISCUSSION
Achieving eﬃcient transcription termination at the correct
termination sites and blocking termination at cryptic
terminators involves a complex interplay between elonga-
tion factors, anti-termination factors and termination
factors, all recruited by elongating RNAP II (8,10). In
this study, we have explored the role of arginine
methylation by Hmt1p in regulating the transition from
transcription elongation to termination. We obtained
evidence that Hmt1p suppresses recognition of the
mutationally weakened terminator at gal10-D56 (Figure
1) and set out to elucidate the mechanism of its
antitermination activity. The increased termination at
gal10-D56 in hmt1D cells could arise from less eﬃcient
transcription elongation, diminished recruitment of an
antitermination factor or increased recruitment of a ter-
mination factor. We found evidence for all three mecha-
nisms. Results from two diﬀerent in vivo assays revealed
that mutants lacking Hmt1p or impaired for its arginine
methyltransferase activity exhibit transcription elongation
defects (Figure 5C), involving a reduced rate of elongation
(Figure 2). This is noteworthy because, apart from
mutation of RNAP II itself, inactivation of various elon-
gation factors was not found to reduce the elongation rate
in vivo (22).
The hmt1 mutants also display decreased recruitment to
GAL10 of the antitermination factor Npl3p, known to
block recognition of the defective gal10-D56 terminator
(8), and they further exhibit elevated occupancies of cleav-
age/termination factor Hrp1p (Figure 3). A previous
genome-wide analysis did not reveal an important role
for Hmt1p arginine methyltransferase activity in
modulating co-transcriptional recruitment of Npl3p or
Hrp1p, although a non-enzymatic function of Hmt1p
was implicated in down-regulating Hrp1p recruitment at
many genes (31). Perhaps the marked eﬀects of Hmt1p
catalytic function on Npl3p and Hrp1p recruitment
observed here are restricted to highly induced genes like
GAL10.
Substituting all of the RGG repeats in Npl3p with
KGG (in the Npl3RKp variant) was shown previously
to mimic the eﬀects of Hmt1p on nuclear export of
Npl3p and its interaction with Tho2p (12,13).
Interestingly, we found that the KGG substitutions also
partially rescue Npl3p recruitment to GAL10 (Figure 4A)
and, consistently, restore the antitermination function
of Npl3p at gal10-D56 in hmt1D cells (Figure 4D).
Remarkably, overexpressing Npl3RKp also rescues eﬃ-
cient recruitment of Tho2p (Figure 5A) and mitigates
the transcription elongation defects in hmt1D cells
(Figure 4E–G and Figure 5C). The fact that substituting
the RGG repeats in Npl3p suppresses the eﬀects of hmt1D
on antitermination, elongation and recruitment of Npl3p
implies that Hmt1p inﬂuences all of these events by
methylating Npl3p rather than another substrate. The
ability of the KGG substitutions to rescue Npl3p
recruitment and transcription elongation ﬁts with
previous ﬁndings that Npl3p directly stimulates elonga-
tion by puriﬁed RNAP II (11). However, the reduced
recruitment of elongation factor Tho2p might also con-
tribute to the elongation defect in hmt1D cells, as Tho2p
recruitment was likewise rescued by overexpressing
Npl3RKp (Figure 5A). This last result is consistent with
previous ﬁndings that Npl3p, but not Npl3RKp, is bound
tightly to Tho2p in an mRNP complex in hmt1D cells. It
was proposed that Hmt1p methylation of Npl3p is
required for its dissociation from Tho2p and other
TREX components to facilitate nuclear export of the
Npl3p-mRNP complex (13,31).
Based on our ﬁndings and the previous results, we
propose that methylation of the RGG repeats in Npl3p
by Hmt1p facilitates mRNA export and leads to dissoci-
ation of TREX (Tho2p) from Npl3p-containing mRNPs
recycling TREX (Tho2p) back to sites of transcription
where it can stimulate elongation. Following mRNA
export, the Npl3p re-enters the nucleus, and is methylated
by Hmt1p (Figures 3C and 4A). Methylated Npl3p is
recruited co-transcriptionally to enhance elongation and
also block recruitment of CFI at cryptic terminators
(Figure 5D, top panel). In hmt1D cells, the TREX–
Npl3p–mRNA complex persists in the nucleus (13,31)
and co-transcriptional recruitment of both Npl3p and
THO/TREX complex are diminished, thereby reducing
the elongation rate and increasing utilization of cryptic
terminators (Figure 5D, middle panel). The KGG substi-
tutions in Npl3p partially rescue mRNA export and
thereby dissociate TREX from the Npl3p–mRNA
complexes independently of Npl3p methylation by
Hmt1p, thus suppressing the elongation and
antitermination defects of hmt1D cells (Figure 5D,
bottom). This model is consistent with the ﬁnding that
the defect in mRNA nuclear export in hmt1D cells is
rescued by overexpressing Npl3RKp (13). It is also sup-
ported by the fact that the transient Tho2p–Npl3p–
mRNA complex has been detected by coimmunopre-
cipitation only in hmt1D cells, which are defective for
mRNA nuclear export (13). Methylation of Npl3p might
enhance its recruitment to sites of elongation by another
more active mechanism besides dissociation of the
putative TREX–Npl3p–mRNA complex postulated in
our model.
The proposed role of Hmt1p in regulating interaction of
Tho2p and Npl3p on nascent mRNAs may provide a
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feedback mechanism for coordinating the rate of tran-
scription elongation with nuclear export. If methylation
of Npl3p is required to enable nuclear export of the
Npl3p–mRNP and recycle TREX (Tho2p), as suggested
in Figure 5D, then the availability of TREX (Tho2p) for
new rounds of transcription elongation will be dependent
on the completion of mRNA export of existing nascent
transcripts.
In addition to methylation, Npl3p can be
phosphorylated by Sky1p (14,15,33) and CK2 (11).
Phosphorylation of Npl3p (on Ser-411) by Sky1p
reduces Npl3p RNA binding aﬃnity and promotes
Npl3p dissociation from mRNA (14). Hence, it is
thought that phosphorylation of Npl3p by Sky1p in the
cytoplasm is important for recycling Npl3p back to the
nucleus (14,15,33) and releasing the transcripts for trans-
lation (34). However, there is evidence that Npl3p
methylation by Hmt1p antagonizes Sky1p-mediated
phosphorylation of Npl3p in vitro (15). Therefore, an
unknown Npl3p demethylase might have to operate in
the cytoplasm to permit Sky1p phosphorylation of
Npl3p. Interestingly, Npl3p is also phosphorylated on
Ser-411 by CK2 in the nucleus (11). This phosphorylation
is suggested to promote Npl3p dissociation from the
nascent transcript, and hence promote the recruitment of
termination factors (11). Our results indicate that the
Npl3p recruited to sites of transcription is methylated by
Hmt1p (Figures. 3C and 4C). Since CK2 phosphorylates
the same site as Sky1p, it is possible that Npl3p
methylation would also antagonize CK2-mediated
phosphorylation at Ser-411 and prevent the proposed
function in dissociation of Npl3p at termination sites.
It is unclear whether methylation of Npl3p would antag-
onize its phosphorylation by CK2 in vivo and the atten-
dant proposed eﬀects of CK2 on termination. It is clearly
of great interest to fully elucidate the sequence and precise
timing of post-translational modiﬁcations of Npl3p
(including methylation, demethylation, phosphorylation
and dephosphorylation) during the transcription cycle,
splicing and mRNA export.
The human homologue of yeast Hmt1p, Prmt1p, was
suggested to aﬀect transcription elongation via
methylation of Spt5p (35) and histone H4 Arg-3 (36,37).
Presumably Npl3RKp does not aﬀect the methylation
of other molecules in hmt1D cells, and thus Npl3RKp
likely rescues the transcription elongation defect conferred
by hmt1D through mechanisms distinct from those
described for Prmt1p, e.g. by promoting TREX (Tho2p)
recruitment (Figure 5D). Hmt1p might also stimulate
elongation via methylation of Npl3p by enhancing
recruitment of Npl3p to elongating RNAP II, as Npl3p
can stimulate elongation in a puriﬁed system lacking
TREX (11,30).
In summary, we have provided the ﬁrst direct evidence
that the arginine methyltransferase activity of Hmt1p
enhances transcription elongation and antitermination
in vivo and that both functions involve its methylation of
RGG repeats in Npl3p, enhancing recruitment of Npl3p
and THO/TREX while impeding recruitment of CFI to
sites of transcription elongation.
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